• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

Recent Advances in the Application of (2-methylpyridin-3-yl)boronic acid (CAS: 899436-71-6) in Chemical Biology and Pharmaceutical Research

The compound (2-methylpyridin-3-yl)boronic acid (CAS: 899436-71-6) has emerged as a versatile building block in chemical biology and pharmaceutical research due to its unique structural and reactivity properties. This boronic acid derivative is particularly valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed in the synthesis of complex organic molecules, including drug candidates and bioactive compounds. Recent studies have highlighted its potential in the development of novel therapeutics and diagnostic tools, leveraging its ability to form stable covalent interactions with biological targets.

One of the most significant applications of (2-methylpyridin-3-yl)boronic acid is in the synthesis of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is implicated in various diseases, including cancer and inflammatory disorders. Researchers have utilized this boronic acid derivative to design and synthesize potent and selective kinase inhibitors, with improved pharmacokinetic properties. For instance, a recent study demonstrated its incorporation into a series of pyridine-based compounds that exhibited nanomolar inhibitory activity against specific kinase targets, paving the way for further preclinical evaluation.

In addition to its role in drug discovery, (2-methylpyridin-3-yl)boronic acid has been explored in the development of fluorescent probes and sensors. Boronic acids are known for their ability to bind diols and other biologically relevant molecules, making them ideal for detecting sugars, glycoproteins, and other analytes. A 2023 study reported the synthesis of a boronic acid-based fluorescent probe incorporating (2-methylpyridin-3-yl)boronic acid, which showed high selectivity for glucose in physiological conditions. This innovation holds promise for continuous glucose monitoring systems, particularly for diabetes management.

Another exciting development involves the use of (2-methylpyridin-3-yl)boronic acid in targeted drug delivery systems. Researchers have functionalized nanoparticles and polymers with this boronic acid to create pH-responsive carriers that release therapeutic agents in specific microenvironments, such as tumor tissues. A recent publication highlighted the successful application of such a system in delivering anticancer drugs with reduced off-target effects and enhanced efficacy. This approach exemplifies the growing trend of combining chemical biology with nanotechnology to address unmet medical needs.

Despite these advancements, challenges remain in the optimization of (2-methylpyridin-3-yl)boronic acid-based compounds. Issues such as solubility, stability, and off-target interactions need to be carefully addressed to ensure clinical translatability. Ongoing research is focused on modifying the boronic acid moiety and exploring novel synthetic routes to overcome these limitations. Collaborative efforts between chemists, biologists, and pharmacologists are essential to fully harness the potential of this compound in therapeutic and diagnostic applications.

In conclusion, (2-methylpyridin-3-yl)boronic acid (CAS: 899436-71-6) continues to be a valuable tool in chemical biology and pharmaceutical research. Its applications span from drug discovery to diagnostic tools, demonstrating its versatility and importance in advancing biomedical science. Future research will likely uncover new roles for this compound, further solidifying its position in the toolkit of researchers and clinicians alike.

• 178055-40-8((2,4,6-Trimethylpyridin-3-yl)boronic Acid)
• 693774-55-9(2,6-Dimethylpyridin-3-ylboronic acid)
• 1011722-07-8((6-Cyanopyridin-3-yl)boronic acid)
• 1072944-22-9((6-Bromo-2-methylpyridin-3-yl)boronic acid)
• 659742-21-9((6-methylpyridin-3-yl)boronic acid)
• 874290-88-7((2-Cyanopyridin-3-yl)boronic acid)
• 1072952-34-1((2-Methylpyridin-3-yl)boronic acid hydrochloride)
• 904326-91-6((6-Fluoro-2-methylpyridin-3-yl)boronic acid)
• 1072952-30-7((6-methyl-3-pyridyl)boronic acid;hydrate)
• 1029654-14-5((2-Phenylpyridin-3-yl)boronic acid)